Peripheral inflammation in behavioural variant frontotemporal dementia: associations with central degeneration and clinical measures
Open Access
- 8 March 2023
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 20 (1) , 1-12
Abstract
Background: Neuroinflammation plays a significant role in the progression of frontotemporal dementia (FTD). However, the association between peripheral inflammatory factors and brain neurodegeneration is poorly understood. We aimed to examine changes in peripheral inflammatory markers in patients with behavioural variant FTD (bvFTD) and explore the potential association between peripheral inflammation and brain structure, metabolism, and clinical parameters. Methods: Thirty-nine bvFTD patients and 40 healthy controls were enrolled and underwent assessment of plasma inflammatory factors, positron emission tomography/magnetic resonance imaging, and neuropsychological assessments. Group differences were tested using Student’s t test, Mann‒Whitney U test, or ANOVA. Partial correlation analysis and multivariable regression analysis were implemented using age and sex as covariates to explore the association between peripheral inflammatory markers, neuroimaging, and clinical measures. The false discovery rate was used to correct for the multiple correlation test. Results: Plasma levels of six factors, including interleukin (IL)-2, IL-12p70, IL-17A, tumour necrosis superfamily member 13B (TNFSF/BAFF), TNFSF12 (TWEAK), and TNFRSF8 (sCD30), were increased in the bvFTD group. Five factors were significantly associated with central degeneration, including IL-2, IL-12p70, IL-17A, sCD30/TNFRSF8, and tumour necrosis factor (TNF)-α; the association between inflammation and brain atrophy was mainly distributed in frontal–limbic–striatal brain regions, whereas the association with brain metabolism was mainly in the frontal–temporal–limbic–striatal regions. BAFF/TNFSF13B, IL-4, IL-6, IL-17A and TNF-α were found to correlate with clinical measures. Conclusion: Peripheral inflammation disturbance in patients with bvFTD participates in disease-specific pathophysiological mechanisms, which could be a promising target for diagnosis, treatment, and monitoring therapeutic efficacy.Keywords
Funding Information
- National Natural Science Foundation of China (82271464)
This publication has 43 references indexed in Scilit:
- TDP-43 frontotemporal lobar degeneration and autoimmune diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseasesInsights into Imaging, 2011
- Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaBrain, 2011
- Presence of Reactive Microglia and Neuroinflammatory Mediators in a Case of Frontotemporal Dementia with P301S MutationNeurodegenerative Diseases, 2011
- Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patientsJournal of Neuroinflammation, 2011
- Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s diseaseBrain, 2010
- Morphological and Glucose Metabolism Abnormalities in Alcoholic Korsakoff's Syndrome: Group Comparisons and Individual AnalysesPLOS ONE, 2009
- Cytokines and CNS DevelopmentNeuron, 2009
- Immune Proteins in Brain Development and Synaptic PlasticityNeuron, 2009
- Pro-Inflammatory Cytokine Genes Influence the Clinical Features of Frontotemporal Lobar DegenerationDementia and Geriatric Cognitive Disorders, 2009